Loading...
Beijing Health (Holdings) Limited
2389.HK•HKSE
Healthcare
Medical - Care Facilities
HK$0.09
HK$-0.00(-1.12%)
Beijing Health (Holdings) Limited (2389.HK) Financial Performance & Income Statement Overview
Review Beijing Health (Holdings) Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
6.84%
↑ 6.84%
Operating Income Growth
8.007%
↑ 8.007%
Net Income Growth
-87.81%
↓ 87.81%
Operating Cash Flow Growth
100.00%
↑ 100.00%
Operating Margin
-43.43%
↓ 43.43%
Gross Margin
17.40%
↑ 17.40%
Net Profit Margin
-77.51%
↓ 77.51%
ROE
-6.60%
↓ 6.60%
ROIC
-3.59%
↓ 3.59%
Beijing Health (Holdings) Limited (2389.HK) Income Statement & Financial Overview
Review Beijing Health (Holdings) Limited's (2389.HK) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $76.64M | $73.31M | $62.31M | $78.04M |
| Cost of Revenue | $66.93M | $56.92M | $53.33M | $71.00M |
| Gross Profit | $9.70M | $16.38M | $8.98M | $7.04M |
| Gross Profit Ratio | $0.13 | $0.22 | $0.14 | $0.09 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $40.47M | $50.74M | $56.84M | $39.25M |
| Operating Expenses | $40.47M | $50.74M | $56.84M | $39.25M |
| Total Costs & Expenses | -$107.40M | $107.66M | $110.17M | $110.25M |
| Interest Income | $4.10M | $742000.00 | $8.18M | $7.43M |
| Interest Expense | $132000.00 | $96000.00 | $113000.00 | $263000.00 |
| Depreciation & Amortization | $10.75M | $1.98M | $12.04M | $12.17M |
| EBITDA | -$28.00M | -$32.37M | -$20.69M | -$484000.00 |
| EBITDA Ratio | -$0.37 | -$0.44 | -$0.57 | -$0.26 |
| Operating Income | -$30.76M | -$34.35M | -$47.86M | -$32.21M |
| Operating Income Ratio | -$0.40 | -$0.47 | -$0.77 | -$0.41 |
| Other Income/Expenses (Net) | -$8.11M | -$15.76M | $858000.00 | $19.29M |
| Income Before Tax | -$38.88M | -$50.11M | -$32.84M | -$12.92M |
| Income Before Tax Ratio | -$0.51 | -$0.68 | -$0.53 | -$0.17 |
| Income Tax Expense | -$1.08M | -$2.76M | -$5.59M | -$1.47M |
| Net Income | -$59.81M | -$56.41M | -$45.87M | -$16.01M |
| Net Income Ratio | -$0.78 | -$0.77 | -$0.74 | -$0.21 |
| EPS | -$0.010 | -$0.009 | -$0.008 | -$0.003 |
| Diluted EPS | -$0.010 | -$0.009 | -$0.008 | -$0.003 |
| Weighted Avg Shares Outstanding | $6.06B | $6.06B | $6.06B | $6.06B |
| Weighted Avg Shares Outstanding (Diluted) | $6.06B | $6.06B | $6.06B | $6.06B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan